Company Filing History:
Years Active: 2024
Title: Alan Marc Williams: Innovator in Cellular Immunotherapy
Introduction
Alan Marc Williams is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of immunotherapy, particularly in the treatment of cancer. His innovative approach focuses on the use of CAR-T cells, which are engineered to enhance the immune response against cancer cells.
Latest Patents
Alan holds a patent for "Cellular immunotherapy for repetitive administration." This invention provides composition kits and methods for treating cancer in humans through immunotherapy. The method utilizes successive doses of CAR-T cells, aiming to minimize or eliminate the anamnestic immune reaction in individuals receiving treatment. He has 1 patent to his name.
Career Highlights
Alan is currently associated with Cellectis, a company known for its pioneering work in gene-editing technologies and immunotherapy. His role at Cellectis allows him to collaborate with leading experts in the field and contribute to groundbreaking advancements in cancer treatment.
Collaborations
Throughout his career, Alan has worked alongside notable colleagues such as David Sourdive and Aymeric Duclert. Their combined expertise has fostered a collaborative environment that drives innovation in cellular therapies.
Conclusion
Alan Marc Williams is a key figure in the development of cellular immunotherapy, with a focus on improving cancer treatment methodologies. His work continues to influence the field and offers hope for more effective cancer therapies in the future.